| Financial Year |
March 31 2023 |
| Monetary Funds |
333,889,987.33 |
| Held-for-trading Financial Assets |
5,000,000.00 |
| Notes Receivable |
61,749,545.64 |
| Accounts Receivable |
3,302,633,433.81 |
| Advances to Suppliers |
256,055,500.53 |
| Other Receivables |
253,584,173.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
688,733,846.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,775,440.80 |
| Total Current Assets |
7,369,708,552.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
21,501,760.10 |
| Long-term Equity Investment |
17,717,300.43 |
| Investment Properties |
49,661,406.29 |
| Fixed Assetes |
855,746,486.91 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
506,800,722.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
86,854,358.98 |
| Deferred Income Tax Assets |
893,567,728.56 |
| Other Non-Current Assets |
48,715,602.26 |
| Sub-Total of Non-Current Assets |
2,702,153,694.05 |
| Total Assets |
10,071,862,246.84 |
| Short-Term Loans |
5,030,173,027.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
710,245,374.55 |
| Accounts Payable |
5,280,485,602.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
115,219,611.46 |
| Taxes Payable |
35,547,170.32 |
| Interest Payable |
487,896,383.82 |
| Dividend Payable |
277,411.35 |
| Other payables |
1,649,524,430.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
896,831,300.99 |
| Other Current Liabilities |
476,054,370.50 |
| Sub-Total of Current Liabilities |
14,648,174,085.90 |
| Long-term Loans |
459,750,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,062,104.06 |
| Deferred Income Tax Liabilities |
9,599,999.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
598,415,258.61 |
| Total Liabilities |
15,246,589,344.51 |
| Paid-In Capital(Or Share Stock) |
1,537,279,657.00 |
| Capital Surplus |
2,333,786,864.22 |
| Surplus Reserve |
380,016,036.69 |
| LESS:Treasury Stock |
556,400.00 |
| Undistributed Profits |
-9,098,588,757.56 |
| Minority Stockholder's Interest |
-244,248,962.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-4,930,478,134.93 |
| Owner's Equity（Stockholder's Equity） |
-5,174,727,097.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,071,862,246.84 |
